Skip to main content
SpringerLink
Log in

Carcinogenic risk in diagnostic nuclear medicine: biological and epidemiological considerations

  • Review Article
  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

Abstract

During the last decade new data have become available on the mechanism of carcinogenesis and on cancer induction by ionizing radiation. This review concentrates on these two items in relation to the use of radiopharmaceuticals in diagnostic nuclear medicine. On the basis of reports of expert committees, the concept of radiation risk is elucidated for high and low doses. Mortality risk factors due to ionizing radiation are put in perspective to other risks. The extra risk for patients who undergo a scintigraphic examination for fatal cancer is very small and is of the order of 1.4×10−4. It is most unlikely that this figure can even be verified by actual measurement since the majority of nuclear medicine patients will die of other causes before the radiogenic cancer manifests itself.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Tubiana M, Dutreix J, Wambersie A, Bewley DK. Introduction to radiobiology. London: Taylor & Francis, 1990.

    Google Scholar 

  2. International Commission on Radiological Protection. 1990 Recommendations of the International Commission on Radiological Protection. ICRP Publication 60. Annals of the ICRP 1991 21:1–3.

    Google Scholar 

  3. International Commission on Radiological Protection. Recommendations of the International Commission on Radiological Protection (adopted January 17, 1977). ICRP Publication 26. Annals of the ICRP 1:3.

  4. Ritenour ER. Health effects of low level radiation: carcinogenesis, teratogenesis, and mutagenesis. Semin Nucl Med 1986; 16:106–117.

    Google Scholar 

  5. United Nations Scientific Committee on the Effects of Atomic Radiation. Genetic and somatic effects of ionizing radiation. UNSCEAR 1986 report to the General Assembly, with annexes. New York: United Nations, 1986.

    Google Scholar 

  6. United Nations Scientific Committee on the Effects of Atomic Radiation. Sources, effects and risks of ionizing radiation. UNSCEAR 1988 report to the General Assembly, with annexes. New York: United Nations, 1988.

    Google Scholar 

  7. Advisory Committee on the Biological Effects of Ionizing Radiation. The effects on populations of exposure to low levels of ionizing radiation. 1980.

  8. Smith PG, Doll R. Age and time dependent changes in the rates of radiation induced cancers in patients with ankylosing spondylitis following a single course of x-ray treatment. Atomic Energy Agency Symposium. March 1978; paper No. TAEA-SM-224/711.C.

  9. Report to Congress of the United States. Problems in assessing the cancer risks of low-level radiation exposure. Washington, DC: United States General Accounting Office, 1981.

  10. Archer V. Epidemiological studies of low-level radiation effects [letter]. Health Phys 1981;40:129.

    Google Scholar 

  11. Radiation risks. Report, 1991/1992 Health Council of The Netherlands. 1991/1992.

  12. Nordling CO. A new theory on the cancer inducing mechanism. Br J Cancer 1953;7:68–72.

    Google Scholar 

  13. Armitage P, Doll R. The age distribution of cancer and a multi-stage theory of carcinogenesis. Br J Cancer 1954;8:1–12.

    Google Scholar 

  14. Committee on the Biological Effects of Ionizing Radiations. Health risks of radon and other internally deposited alphaemitters. BEIR IV. 1988.

  15. United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR). Sources, effects and risks of ionizing radiation. 1988.

  16. Boice JD, Engholm G, Kleinerman RA, et al. Radiation dose and leukemia risk in patients treated for cancer of the cervix. Natl Cancer Inst 1987;79:1295–1311.

    PubMed  Google Scholar 

  17. Boice JD, Engholm G, Kleinerman RA, et al. Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat Res 1988;116:3–55.

    Google Scholar 

  18. Bishop JM. Cellular oncogenes and retroviruses. Annu Rev Biochem 1983;52:301–354.

    Google Scholar 

  19. Hall EJ, Freyer GA. The molecular biology of radiation carcinogenesis. In: Glass MNV, ed. Physics and chemical mechanisms in molecular biology. New York: Plenum Press; 1991:3–25.

    Google Scholar 

  20. Moolgavkar SH, Knudson AG. Mutation and cancer: A model for human carcinogenesis. J Natl Cancer Inst 1981;66:1037–1052.

    Google Scholar 

  21. Holland JF, Frei E, Bast RC, Kufe DW, Morton DL, Weichselbaum RR. Cancer medicine, 3rd edn, vol 1, Malvern, Penn.: Lea & Febiger, 1993.

    Google Scholar 

  22. Han A, Elkind MM. Enhanced transformation of mouse 1OT 1/2 cells by 12-O-tetradecanolyphorbol-13-acetate following exposure to X-rays or to fission-spectrum neutrons. Cancer Res 1982;42:477–483.

    Article  CAS  PubMed  Google Scholar 

  23. Borek C. Radiation oncogenesis in culture. Adv Cancer Res 1982;37:159–232.

    Google Scholar 

  24. Fry RJM. Relevance of animal studies to the human experience. In: Boice JD Jr, Fraumani JF Jr (eds). Radiation carcinogenesis: epidemiology and biological significance. New York: Raven Press; 1984:337–346.

    Google Scholar 

  25. Committee on the Biological Effects of Ionizing Radiations. The effects on population of exposure to low levels of ionizing radiation. BEIR III. Washington: National Academy of Sciences, 1980.

    Google Scholar 

  26. Upton A (ed) Radiation carcinogenesis. New York: Elsevier, 1986.

    Google Scholar 

  27. Rowland RE, Stehney AF, Lucas HE. Dose-response relationship for radium-induced bone sarcomas. Health Phys 1983;44 Suppl 1:15–31.

    Google Scholar 

  28. Matanoski G, Seltser R, Sartwell P, et al. The current mortality rates of radiologists and other physician specialists: specific causes of death. Am J Epidemiol 1975;101:199–210.

    Google Scholar 

  29. Court Brown W, Doll R. Expectation of life and mortality from cancer among British radiologists. Br Med J 1958;21:181–187.

    Google Scholar 

  30. Kitabatake T, Watanabe T, Koga S. Radiation cancer in Japanese radiological workers. Strahlentherapie 1973;146:599–606.

    Google Scholar 

  31. Court Brown WM, Doll R. Mortality from cancer and other causes after radiotherapy for ankylosing sondylitis. Br Med J 1965;2:1327–1332.

    Google Scholar 

  32. Darby SC, Doll R, Gill SK, Smith PG. Long-term mortality after a single treatment course with X-rays in patients treated for ankylosing spondylitis. Br J Cancer 1987;55:179–190.

    Google Scholar 

  33. Hempelmann L, Hall W, Philips M, et al. Neoplasms in persons treated with X-ray in infancy: fourth survey in 20 years. J Natl Cancer Inst 1975;55:519–530.

    Google Scholar 

  34. Shore RE, Hempelmann LH, Kowaluk E, et al. Breast neoplasms in women treated with X-rays for acuted postpartum mastitis. J Natl Cancer Inst 1977;59:813–822.

    Google Scholar 

  35. Modan B, Ron E, Werner A. Thyroid cancer following scalp irradiation. Radiology 1977;123:741–744.

    Google Scholar 

  36. Smit P, Doll R. Late effects of X-irradiation in patients treated for metropathia haemorrhagica. Br J Radial 1976;49:224–232.

    Google Scholar 

  37. Holm LF, Wiklund KE, Lundell GE, et al. Thyroid cancer after diagnostic doses of iodine-131: a retrospective cohort study. J Natl Cancer Inst 1988;80:1132–1138.

    Google Scholar 

  38. Clarke RH, Southwood TRE. Risks from ionizing radiation. Nature 1989;338:197–198.

    Google Scholar 

  39. Shimizu Y, Kato H, Schull WJ, Preston D, Fujita S, Pierce D. Life span study report 11, part 1 — Comparison of risk coefficents for site specific cancer mortality based on the DS86 and T65DR shielded kerma and organ doses. Technical report RERF TR12–87. Hiroshima, Japan: Radiation Effects Research Foundation, 1987.

    Google Scholar 

  40. Shimizu Y, Kato H, Schull WJ. Life span study report 11, part 2 — Cancer mortality in the years 1950–1985 based on the recently revised doses (DS86). Technical report RERF TR 5–88. Hiroshima, Japan: Radiation Effects Research Foundation. 1988.

    Google Scholar 

  41. Wakabayaski T, Kato H, Ikeda T, Schull WJ. Studies of the mortality of A-bomb survivors. Radiat Res 1983;93:112–146.

    CAS  Google Scholar 

  42. Beebe GW, Kato H, Land CE. Mortality experience of A-bomb survivors, 1950–1974. Radiation Effects Research Foundation, RERF Technical Report No. 1. 1977.

  43. Ishimaru T, Hoshina T, Ichimaru M, et al. Leukaemia in atomic bomb survivors. Hiroshima and Nagasaki, 1 October 1950–30 September 1966. Radiat Res 1971;45:216–233.

    Google Scholar 

  44. Kato H, Schull WJ. Studies of the mortality of the A-bomb survivors. Radiat Res 1982;90:395–432.

    Google Scholar 

  45. Land CE, Sinclair WK. The relative contributions of different organ sites to the total cancer mortality associated with lowdose radiation exposure. Annals of the ICRP 1991;22:31–57.

    Google Scholar 

  46. Pierce DA, Vaeth M. Cancer risk estimation from the A-bomb survivors: extrapolation to low doses, use of relative risk models, and other uncertainties. Report RERF CR 2–89. Hiroshima, Japan: Radiation Effects Research Foundation, 1989.

    Google Scholar 

  47. Muirhead CR, Darby SC. Modelling the relative and absolute risks of radiation-induced cancers. J R Statist Soc A 1987;150 part 2:83–118.

    Google Scholar 

  48. Preston DL, Kato H, Kopecky KJ, Fujita S. Cancer mortality among A-bomb survivors in Hiroshima and Nagasaki 1950–82. Radiation Effects Research Foundation. Life Span Study report 10, part 1. Hiroshima: RERF, 1987.

  49. Latarjet R, Tubiana M. The risks of induced carcinogenesis after irradiation at small doses. The uncertainties which remain after the 1988 UNSCEAR report. Int J Radiat Oncol 1989;17:237–240.

    Google Scholar 

  50. NIH. Report of the National Institutes of Health ad hoc Working Group to Develop Radioepidemiological Tables. NIH Publication 85–2748. Washington DC: US Department of Health and Human Services, 1985.

    Google Scholar 

  51. BEIR. Report, US National Research Council Washington DC: National Academy Press, 1980.

  52. Dunster HJ. An empirical examination of the effects of latency on the fatal risks of ionising radiation. J Soc Radial Prot 1986;6:15–21.

    Google Scholar 

  53. Darby SC, Nakashima E, Kato H. A parallel analysis of cancer mortality among atomic bomb survivors and patients with ankylosing spondylitis given X-ray therapy. J Natl Cancer Inst 1985;75:1–21.

    Google Scholar 

  54. Darby SC, Doll R, Pike MC. Detection of late effects of ionizing radiation: why deaths of A-bomb survivors area valuable resource. Intl J Epidemiol 1985;14:637–638.

    Google Scholar 

  55. Land CE, Boice JD, Shore FE, Norman JE, Tokunaga M. Breast cancer risk from low dose exposures to ionizing radiation: results of parallel analysis of three exposed population of women. J Natl Cancer Inst 1980;65:353–376.

    Google Scholar 

  56. Pochin EE. Radiation risks in perspective. Br J Radial 1987;60:42–50.

    Google Scholar 

  57. ICRP. Quantitative bases for developing a unified index of harm. ICRP Publication 45. Annals of the ICRP 1985;15(3):1–64.

    Google Scholar 

  58. United Nations Scientific Committee on the Effects of Atomic Radiation. Sources and effects of ionizing radiation. UNSCEAR 1977 report to the General Assembly, with annexes. New York: United Nations, 1982.

    Google Scholar 

  59. Roberts PJ. Changes in dose limitation. Nucl Med Commun 1989;10:1–3.

    Google Scholar 

  60. Committee on the Biological Effects of Ionizing Radiations. Health effects of exposure to low levels ionizing radiation. BEIR V. Washington DC: National Academy Press, 1990.

    Google Scholar 

  61. Land CE. Estimating cancer risks from low doses of ionizing radiation. Science 1980;209:1197–1203.

    Google Scholar 

  62. Doll R, Darby SC. Occupational epidemiology: problems in reaching an overview. In: Health effects of low dose ionizing radiation. BNES, London, 1988.

    Google Scholar 

  63. Gilbert ES, Fry SA, Wiggs LD, et al. Analyses of combined mortality data on workers at the Hanford Site, Oak Ridge National Laboratory, and Rocky Flats Nuclear Weapons Plant. Radiat Res 1989;120:19–35.

    Google Scholar 

  64. Beral V, Fraser P, Carpenter L, et al. Mortality among workers at Oak Ridge National Laboratory. JAMA 1991;265:1397–1402.

    Google Scholar 

  65. Wing S, Shy CM, Wood JL, et al. Mortality among workers at Oak Ridge National Laboratory. JAMA 1991;265:1397–1402.

    Google Scholar 

  66. United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR). Ionizing radiation: sources and biological effects. United Nations, New York, 1982.

    Google Scholar 

  67. Upton AC. Cancer induction and non-stochastic effects. Br J Radiol 1987;60:1–16.

    Google Scholar 

  68. Hill CK, Carnes BA, Han A, Elkind MM. Neoplastic transformation is enhanced by multiple low doses of fission-spectrum neutrons. Radiat Res 1985;102:404–410.

    Google Scholar 

  69. Han A, Hill CK, Elkind MM. Repair of cell killing and neoplastic transformation at reduced dose rates of 60Co y-rays. Cancer Res 1980;40:3328–3332.

    Google Scholar 

  70. Broerse JJ, Gerber GB. Neutron carcinogenesis. 1982; Report EUR 8084 (CEC, Luxembourg).

  71. United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR). Sources and effects of ionizing radiation (UNE 77 IX 1). Report to the General Assembly, United Nations, New York, 1977.

    Google Scholar 

  72. NIH. Report of the National Institutes of Health ad hoc Working Group to Develop Radioepidemiological Tables. NIH Publication 85–2748. Washington DC: US Department of Health and Human Services, 1985.

    Google Scholar 

  73. Broerse JJ, Bekkum DW, Zurcher C. Radiation carcinogenesis in experimental animals. Experientia 1989;45:60–69.

    Google Scholar 

  74. Stather JW, Muirhead CR, Edwards AA, et al. Health effects models developed from the 1988 UNSCEAR report. Didcot, UK: National Radiological Protection Board. NRPB-R226, 1988.

    Google Scholar 

  75. International Commission on Radiological Protection. 1990 Recommendations of the International Commission on Radiological Protection. ICRP Publication 60. Annals of the ICRP 1991;21:1–3.

    Google Scholar 

  76. Jammet HP. Problems poses par les irradiations accidentelles prolongees. Bull Acad Nat 1979;163:148–160.

    Google Scholar 

  77. Huda W, Gordon K. Nuclear medicine staff and patient doses in Manitoba (1981–1985). Health Phys 1989;56:277–285.

    Google Scholar 

  78. Beekhuis H. Population radiation absorbed dose from nuclear medicine procedures in The Netherlands. Health Phys 1988;54(3):287–291.

    Google Scholar 

  79. Beentjes LB, Timmermans CWM. Age and sex specific population -dose (SED and GSD) due to nuclear medicine procedures in The Netherlands. Nucl Med Biol 1990;17:261–268.

    Google Scholar 

  80. Johansson L, Mattsson S, Nosslin B, Leide-Svegborn S. Effective dose from radiopharmaceuticals. Eur J Nucl Med 1992;19:933–938.

    Google Scholar 

  81. Huda W, McLellan J, McLellan Y, How will the new definition of “effective dose” modify estimates of dose in diagnostic radiology? J Radiol Prot 1991;11:241–247.

    Google Scholar 

  82. Mettler FA, Christie JH, Williams AG Jr, Moseley RD Jr, Kelsey CA. Population characteristics and absorbed dose to the population from nuclear medicine: United States-1982. Health Phys 1986;50:619–628.

    Google Scholar 

  83. Pochin EE. Quantification of risk in medical procedures. Proc R Soc London 1981;A376:87–101.

    Google Scholar 

  84. Cohen BL. Catalog of risks extended and updated. Health Phys 1991;61:317–335.

    Google Scholar 

  85. Harding LK, Bossuyt A, Pellet S, Reiners C, Talbot JN. EANM Task Group explaining risks. Eur J Nucl Med 1993;20:A15-A24.

    Google Scholar 

  86. Jablon S, Bailar SC. The contribution of ionizing radiation to cancer mortality in the United States. Prev Med 1980;9:219–226.

    Google Scholar 

  87. Pochin EE. Problems involved in detecting increased malignancy rates in the areas of high natural radiation background. Health Phys 1976;31:148–154.

    Google Scholar 

  88. Frigerio NA, Stowe RS. Carcinogenic and genetic hazard from background radiation, in biological and environmental effects of low-level radiation. Vienna: International Atomic Energy Agency; 1976: 385–393.

    Google Scholar 

  89. High Background Radiation Research Group China. Health survey in high background radiation areas in China. Science 1980;290:877–890.

    Google Scholar 

  90. Friere-Mafia A, Friere-Mafia DV. Mortality rates in a Brazilian area of high background radiation. Preliminary analysis based on official records [abstract]. Nucl Sci 1968;22:38453.

    Google Scholar 

  91. Mills WA, Youmans HD. Population exposures from natural background radiation in Kerala, India [abstract]. Health Phys 1968;15:188.

    Google Scholar 

  92. Hickey RJ, Bowers EJ, Scence DE, et al. Low level ionizing radiation and human mortality: multi-regional epidemiological studies. Health Phys 1981;40:624–641.

    Google Scholar 

  93. Nambi KSV, Soman SD. Further observations on environmental radiation and cancer in India. Health Phys 1990;59:339–344.

    Google Scholar 

  94. Hengstler JG, Bockisch A, Loffler S, et al. Therapy with I-131 reduces the number of DNA single strand breaks in mononuclear blood cells of patients [abstract]. Eur J Nucl Med 1993;20:893.

    Google Scholar 

  95. Sagan LA. What is hormesis and why haven't we heard about it before? Health Phys 1987;52:521–525.

    Google Scholar 

  96. Goodhead, DT. Deductions from cellular studies of inactivation, mutagenesis, and transformation. In: Boice JD Jr, Fraumenti JF Jr (eds) Radiation carcinogenesis: epidemiology and biological significance. New York: Raven Press; 1984:337–346.

    Google Scholar 

  97. Broerse JJ, Davelaar J, Zurcher C. Tumour induction in animals and the radiation risk for man. In: Swenberg CE et al., ed. Biologic Effects and Physics of Solar and Galactic Cosmic Radiation, part A. New York:Plenum Press, 1983.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Diagnostic Radiology and Nuclear Medicine, University Hospital Leiden, The Netherlands

    F. Overbeek & E. K. J. Pauwels

  2. Department of Clinical Oncology (Radiation Physics), University Hospital Leiden, The Netherlands

    J. J. Broerse

Authors
  1. F. Overbeek
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. K. J. Pauwels
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. J. Broerse
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Overbeek, F., Pauwels, E.K.J. & Broerse, J.J. Carcinogenic risk in diagnostic nuclear medicine: biological and epidemiological considerations. Eur J Nucl Med 21, 997–1012 (1994). https://doi.org/10.1007/BF00238128

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00238128

Key words

Search

Navigation